PetVivo Recieves Notice Of Allowance From U.S. Patent and Trademark Office For Patent Titled "Protein Biomaterials And Biocoacervates And Methods Of Making And Using Thereof"
Portfolio Pulse from Benzinga Newsdesk
PetVivo Holdings Inc. has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent titled 'Protein Biomaterials And Biocoacervates And Methods Of Making And Using Thereof'. This notice is a significant step towards the granting of the patent, which can enhance the company's intellectual property portfolio and potentially provide a competitive edge in the market.
January 23, 2024 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
PetVivo Holdings Inc. is expected to receive a patent for 'Protein Biomaterials And Biocoacervates', which may bolster its product offerings and market position.
The Notice of Allowance for a patent typically leads to an increase in a company's intellectual property value. For PetVivo, this patent can protect its innovations, potentially leading to increased investor confidence and a competitive advantage in the market. This could result in a positive short-term impact on the stock price as the market reacts to the strengthening of the company's IP portfolio.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100